Inceptor Bio has entered an agreement to acquire Arranta Bio’s 29,000 square foot process development and GMP clinical manufacturing facility and the transfer of a core operating team to establish cell therapy...
Arranta Bio, a microbiome contract development and manufacturing organization (CDMO), has announced the mechanical completion of GMP suites at its Watertown, MA commercial-ready facility.